Monitor Q1 2026 earnings release on May 7 for any guidance changes or unexpected financial results. The CFO transition is orderly, reducing near-term disruption risk.
VTRS drugs
VTRS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 5 $15.52entry
- T+1 · 7mo ago +2.77%α +1.39% · $15.95
- T+5 · 6mo ago +10.63%α +8.65% · $17.17
- T+20 · 6mo ago +1.10%α −3.86% · $15.69
- T+60 · 4mo ago +14.43%α +11.69% · $17.76
Price Chart
How similar events traded
Executive Summary
Viatris CFO Theodora Mistras voluntarily departs for another opportunity; CAO Paul Campbell appointed interim CFO effective May 8, 2026. The transition is orderly with no accounting disagreements, and the company will report Q1 2026 results on May 7.
Key Facts
- CFO Theodora Mistras voluntarily resigns effective May 8, 2026, stays through May 22 for transition.
- Paul Campbell, Chief Accounting Officer, named interim CFO.
- Departure not related to accounting or financial statement disagreements.
- Mistras not eligible for severance or equity vesting; eligible for pro-rata 2026 bonus (at target).
- Q1 2026 earnings scheduled for release on May 7, 2026.
Financial Impact
No immediate financial impact from the CFO transition; Q1 earnings pending.
Risk Factors
- Potential disruption during CFO search if permanent replacement is delayed.
- Q1 earnings miss could compound uncertainty from leadership transition.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-018887 |
| Document: ef20072373_ex99-1.htm | 0001140361-26-018887 |
| Document: 0001140361-26-018887-index-headers.html | 0001140361-26-018887 |
| Document: 0001140361-26-018887-index.html | 0001140361-26-018887 |
| Document: 0001140361-26-018887.txt | 0001140361-26-018887 |
Track record
22 reports on VTRS
3 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +16.85% at T+60 after the Aug 6, 2026 report. 7 of 9 went positive at some point.
Filters
- Nov 17, 2026today 8-K Neutral 4/10 Entry $20.51 Now $20.49 −0.10% settles Feb 16
- Nov 17, 2026today Press Release Neutral 4/10 Entry $20.89 Now $20.49 −1.91% settles Feb 16
- Nov 16, 20261d ago SC 13G/A Neutral 2/10 Entry $20.84 Now $20.49 −1.68% settles Feb 12
- Nov 6, 202611d ago SC 13G/A Neutral 2/10 Entry $19.91 Now $20.49 +2.91% settles Feb 4
- Nov 5, 202612d ago 8-K Mixed 6/10 Entry $18.97 Now $20.49 +8.01% settles Feb 3
- Nov 4, 202613d ago Press Release Neutral 2/10 Entry $19.22 Now $20.49 +6.61% settles Feb 2
- Oct 30, 202618d ago Press Release Bullish 6/10 Entry $19.04 Now $20.49 +7.64% settles Jan 28
- Oct 29, 202619d ago Institutional Cluster Bullish 4/10 Entry $19.20 Now $20.49 +6.72% settles Jan 27
- Oct 16, 20264w ago Press Release Bullish 6/10 Entry $18.26 Now $20.49 +12.21% settles Jan 14
- Oct 8, 20265w ago 8-K Bullish 7/10 Entry $17.44 Now $20.49 +17.49% settles Jan 5
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers